The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.
Total Entries: 1332
| Date | Presenter | Affiliation | Title |
|---|---|---|---|
| May 10, 2022 | No Seminar | Annual Hope Center Retreat | |
| May 3, 2022 | Debra Oliver | WashU Medicine | Lab for Caregiving Innovation in Palliative Medicine Research: ADRD Research with caregivers |
| April 26, 2022 | Susan Resnick, PhD | National Institute on Aging | Predictors of Cognitive Impairment and Resilience: Insights from the BLSA |
| April 19, 2022 | Celeste Karch, PhD | WashU Medicine | Knight ADRC Biomarker Core: Somatic and Stem Cell Models of Alzheimer Disease |
| April 12, 2022 | Tsai Li Huei, PhD | WashU Medicine | Gamma Oscillations: Mechanisms, Function and Human Diseases |
| April 5, 2022 | Joyce (Joy) Balls-Berry, PhD, MPE | WashU Medicine | In Our Right Mind: Alzheimer and Other Dementias’ Impact in Communities of Color |
| March 29, 2022 | Beau Ances, MD, PhD | WashU Medicine | You Are What You Eat: Gut Microbiome Alterations in Preclinical Alzheimer Disease |
| March 22, 2022 | James Fitzpatrick, PhD | WashU Medicine | Amyloid Aggregates: Friend or Foe? |
| March 15, 2022 | Andrea Denny, JD, MSSW & Jennifer Phillips, MPA | WashU Medicine | Improving Dementia Care Outcomes Statewide: The Dementia ECHO Program |
| March 8, 2022 | Naresha Saligrama, PhD | WashU Medicine | T cells in Neurological and Autoimmune diseases |
| March 1, 2022 | Maud Gratze, PhD | WashU Medicine | Can TREM2 deletion counteract the detrimental effect of ApoE4 on tau-mediated neurodegeneration? |
| February 22, 2022 | Justin Long, MD, PhD | WashU Medicine | Oxysterols in tau-mediated neurodegeneration |
| February 15, 2022 | John C. Morris, MD | WashU Medicine | The Clinical Core of the Knight ADRC |
| February 8, 2022 | Mark Sands, PhD | WashU Medicine | Haploinsufficiency of Lysosomal Enzymes and Alzheimer Disease |
| February 1, 2022 | Rebecca Fierberg, MSW | WashU Medicine | Behaviors and Communication in Dementia Care: Strategies for empowering caregivers and individuals with memory loss |
| January 25, 2022 | Zachariah Reagh, PhD | WashU | Selective vulnerability of two cortico-hippocampal networks in the aging brain |
| January 18, 2022 | Chengjie Xiong, MD | WashU Medicine | Racial Difference in Alzheimer Disease: Yes, No, or It Depends…? |
| January 11, 2022 | Tricia See, ScM, CGC | Informed DNA | Genetic Counseling for Early Onset Alzheimer’s Disease: Predictive testing considerations |
| January 4, 2022 | John C. Morris, MD | WashU Medicine | The Importance of Diversity in Alzheimer Disease Clinical Practice and Research |
| December 28, 2021 | No Seminar | Winter Break | |
| December 21, 2021 | No Seminar | Winter Break | |
| December 14, 2021 | Gregg Day, MD | Mayo Clinic | Rapidly Progressive Dementia: Improving Recognition, Diagnosis and Treatment |
| December 7, 2021 | Andrea Denny, JD, MSSW, Myrtis Spencer, and AAAB | WashU Medicine / AAAB | The Knight Alzheimer Disease Research Center’s African American Advisory Board (AAAB): A Brief History |
| November 30, 2021 | Julie Wisch, PhD | WashU Medicine | Proteomic Clusters Underlie Heterogeneity in Preclinical AD Progression |
| November 23, 2021 | Eric McDade, Randy Bateman, Chengjie Xiong, Yan Li, Suzanne Schindler | WashU Medicine | Highlights of the 14th Annual Clinical Trials in Alzheimer Disease |